Join Paid Clinical Trials for Sexual Diseases in

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Sexual Disease

Top of Directory » All Categories » by Illness » Sexual Disease



  • Computerized Counseling to Promote Positive Prevention and HIV Health in Kenya

    Condition:   HIV Infections
    Interventions:   Other: CARE+ Kenya brief computer risk assessment session;   Other: CARE+ Kenya computer counseling session
    Sponsors:   New York University;   Indiana University;   Moi University
    Not yet recruiting - verified November 2009
  • A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]

    Condition:   HIV Infections
    Interventions:   Other: CARE+ Spanish computer counseling session;   Other: CARE+ Spanish brief computer risk assessment session
    Sponsors:   New York University;   St. Vincent's Medical Center
    Not yet recruiting - verified November 2009
  • Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults

    Conditions:   Tuberculosis;   HIV Infections
    Interventions:   Biological: AERAS-402;   Biological: Placebo Control
    Sponsors:   Aeras Global Tuberculosis Vaccine Foundation;   Crucell Holland BV
    Not yet recruiting - verified November 2009
  • Appropriate Timing of HAART in Co-infected HIV/TB Patients

    Conditions:   HIV Infections;   Tuberculosis
    Intervention:   Drug: tenofovir, lamivudine, efavirenz
    Sponsors:   Bamrasnaradura Infectious Diseases Institute;   Mahidol University;   Thai Red Cross AIDS Research Centre
    Recruiting - verified November 2009
  • Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) in Antiretroviral-naïve HIV-infected Individuals.

    Condition:   HIV Infections
    Interventions:   Drug: Efavirenz;   Drug: Efavirenz
    Sponsor:   The National Centre in HIV Epidemiology and Clinical Research
    Not yet recruiting - verified November 2009
  • A Study With RO4917523 in Patients With Fragile X Syndrome

    Condition:   Fragile X Syndrome
    Interventions:   Drug: RO4917523;   Drug: Placebo;   Drug: RO4917523;   Drug: Placebo
    Sponsor:   Hoffmann-La Roche
    Not yet recruiting - verified November 2009
  • Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects

    Conditions:   Hypertriglyceridemia;   HIV Infection
    Interventions:   Dietary Supplement: Lovaza;   Drug: fosamprenavir/ritonavir
    Sponsors:   Felizarta, Franco, M.D.;   GlaxoSmithKline
    Recruiting - verified November 2009
  • Caverject User Study

    Condition:   Erectile Dysfunction
    Intervention:   Other: delivery system
    Sponsor:   Pfizer
    Not yet recruiting - verified November 2009
  • Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4

    Conditions:   Liver Cirrhosis;   Hepatitis C Virus;   HIV Infection
    Intervention:   Drug: Pegylated interferon alfa-2a and Ribavirin
    Sponsor:   Sociedad Andaluza de Enfermedades Infecciosas
    Recruiting - verified October 2009
  • Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder

    Condition:   Posttraumatic Stress Disorder (PTSD)
    Interventions:   Drug: orvepitant;   Other: Placebo
    Sponsor:   GlaxoSmithKline
    Not yet recruiting - verified October 2009
  • Artery Elasticity After Switch From Epzicom to Truvada

    Condition:   HIV Infections
    Intervention:   Drug: Tenofovir disoproxil
    Sponsor:   Minneapolis Medical Research Foundation
    Recruiting - verified October 2009
  • Side-to-end Anastomosis Versus Colon J Pouch for Reconstruction After Low Anterior Resection for Rectal Cancer (SAVE)

    Condition:   Rectal Cancer
    Interventions:   Procedure: side-to-end anastomosis;   Procedure: colon j pouch
    Sponsors:   Charite University, Berlin, Germany;   ChirNet
    Not yet recruiting - verified November 2009
  • Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV

    Conditions:   HIV Infections;   H1N1 Influenza
    Interventions:   Biological: Arepanrix;   Biological: Arepanrix
    Sponsors:   University of British Columbia;   Canadian Institutes of Health Research (CIHR)
    Not yet recruiting - verified October 2009
  • ADHEPTA Study: Adherence Questionnaire in Hepatitis C

    Conditions:   Hepatitis C, Chronic;   HIV Infection
    Intervention:   Other: Adherence questionnaire
    Sponsor:   IMS Health
    Recruiting - verified October 2009
  • Pilot Study of Text Message Reminders to Improve HIV Medication Adherence in Botswana

    Condition:   HIV Infections
    Intervention:   Other: Cell phone text message
    Sponsor:   University of Pennsylvania
    Recruiting - verified October 2009
  • TMC278-TiDP6-C154: Evaluation of the Possible Influence of Omeprazole Intake - and the pH Increase in the Stomach Triggered by Omeprazole Intake - on the Blood Levels of TMC278 in Healthy Volunteers

    Condition:   HIV Infections
    Intervention:   Drug: TMC278; Omeprazole
    Sponsor:   Tibotec Pharmaceuticals, Ireland
    Not yet recruiting - verified November 2009
  • Integrating Family Planning Services Into HIV Care and Treatment in Nyanza Province, Kenya

    Conditions:   Unintended Pregnancy;   HIV Infections
    Intervention:   Procedure: Integrated family planning/HIV care and treatment services
    Sponsors:   University of California, San Francisco;   Ibis Reproductive Health;   Kenya Medical Research Institute;   Tides Foundation
    Recruiting - verified October 2009
  • Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults

    Conditions:   Pneumococcal Vaccines;   HIV;   HIV Infections
    Intervention:   Biological: Prevenar and Pneumo23
    Sponsors:   Hospital Universitari Son Dureta;   Hospital Son Llatzer;   Fondo de Investigacion Sanitaria
    Recruiting - verified October 2009
  • Neuropsychologic, Neuroradiologic, Endocrinologic, and Genetic Aspects of Klinefelter Syndrome

    Condition:   Klinefelter Syndrome
    Intervention:  
    Sponsors:   University of Aarhus;   Aarhus University Hospital
    Not yet recruiting - verified October 2009
  • Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons

    Conditions:   Influenza;   H1N1;   HIV;   Vaccine;   HIV Infections
    Intervention:  
    Sponsors:   Uniformed Services University of the Health Sciences;   Infectious Disease Clinical Research Program;   National Institute of Allergy and Infectious Diseases (NIAID)
    Not yet recruiting - verified October 2009
  • The Women's HIV SeroIncidence Study (ISIS)

    Condition:   HIV Infections
    Intervention:  
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified June 2009
  • The Shang Ring: A Novel Male Circumcision Device for HIV Prevention

    Conditions:   Male Circumcision;   HIV Prevention;   HIV Infections
    Intervention:   Device: Shang Ring circumcision
    Sponsors:   Weill Medical College of Cornell University;   Engenderhealth
    Recruiting - verified October 2009
  • Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth

    Conditions:   HIV Infections;   H1N1 Influenza Virus
    Intervention:   Biological: Influenza A (H1N1) 2009 monovalent vaccine
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Not yet recruiting - verified October 2009
  • Randomised and Prospective Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens

    Condition:   HIV Infections
    Interventions:   Drug: Darunavir/ritonavir;   Drug: Lopinavir/ritonavir
    Sponsor:   Germans Trias i Pujol Hospital
    Not yet recruiting - verified October 2009
  • Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

    Conditions:   HIV-1 Infection;   HIV Infections
    Interventions:   Drug: maraviroc;   Drug: darunavir;   Drug: ritonavir
    Sponsors:   Northwestern University;   Pfizer;   Tibotec, Inc
    Not yet recruiting - verified October 2009
  • Adding Nitazoxanide to Treatment for People With Hepatitis C Virus and HIV Coinfection

    Conditions:   HIV Infections;   Hepatitis C Virus
    Interventions:   Drug: Nitazoxanide (NTZ);   Drug: Peginterferon alfa-2a (PEG-INF);   Drug: Ribavirin (RBV)
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Not yet recruiting - verified October 2009
  • Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

    Conditions:   HIV Infections;   H1N1 Influenza Virus
    Intervention:   Biological: Influenza A (H1N1) monovalent vaccine
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified October 2009
  • Durability of Adherence in Self-Management of HIV (The DASH Study)

    Condition:   HIV Infections
    Intervention:   Behavioral: Modified client adherence profiling and intervention tailoring (CAP-IT)
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Not yet recruiting - verified October 2009
  • Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults

    Condition:   HIV Infections
    Interventions:   Biological: PENNVAX-B;   Biological: IL-12 DNA plasmids
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified August 2009
  • Europe-Africa Research Network for Evaluation of Second-line Therapy

    Conditions:   Human Immunodeficiency Virus;   HIV Infections
    Interventions:   Drug: Aluvia + 2NRTIs;   Drug: Aluvia + raltegravir;   Drug: Aluvia monotherapy
    Sponsors:   Medical Research Council;   European and Developing Countries Clinical Trials Partnership
    Not yet recruiting - verified September 2009
  • Effect of Rosuvastatin on Cardiovascular Risk in HIV-Infected Individuals With Low High Density Lipoprotein (HDL) Cholesterol

    Conditions:   HIV Infections;   Cardiovascular Disease
    Intervention:   Drug: rosuvastatin
    Sponsor:   University of Hawaii
    Not yet recruiting - verified September 2009
  • Study on the Psychotherapeutic Treatment for the Feeling of Being Contaminated After Childhood Sexual Abuse

    Conditions:   Sexual Abuse;   Posttraumatic Stress Disorder
    Interventions:   Behavioral: Information on skin exchange and guided imagery modification;   Behavioral: Exploration
    Sponsor:   Johann Wolfgang Goethe University
    Recruiting - verified October 2009
  • Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Women

    Conditions:   Malaria;   HIV Infections
    Interventions:   Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Zidovudine;   Drug: Lamivudine
    Sponsors:   University of California, San Francisco;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Not yet recruiting - verified October 2009
  • Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV

    Condition:   HIV Infections
    Intervention:   Drug: Raltegravir
    Sponsor:   Germans Trias i Pujol Hospital
    Not yet recruiting - verified October 2009
  • Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet

    Conditions:   HIV Prevention;   HIV Infections
    Interventions:   Drug: Tenofovir;   Drug: HEC Placebo
    Sponsors:   CONRAD;   National Institute of Allergy and Infectious Diseases (NIAID);   Microbicide Trials Network
    Recruiting - verified September 2009
  • Redirected High Affinity Gag‐Specific Autologous T Cells for HIV Gene Therapy

    Condition:   HIV Infections
    Interventions:   Biological: WT-gag-TCR modified T cells;   Biological: α/6-gag-TCR modified T cells;   Other: STI or Drug Holiday
    Sponsor:   University of Pennsylvania
    Not yet recruiting - verified November 2009
  • Non-Invasive Sexually Transmitted Disease (STD) Testing in Women Seeking Emergency Contraception: Meeting the Needs of an At-Risk Population

    Conditions:   Trichomonas Vaginalis Infection;   Chlamydia Trachomatis;   Neisseria Gonorrhoeae
    Intervention:  
    Sponsors:   University of Pittsburgh;   Gen-Probe, Incorporated
    Recruiting - verified November 2009
  • Genotype Based Personalized Prescription of Nevirapine

    Conditions:   Nevirapine Induced Rash;   Nevirapine Induced Hepatitis;   HIV;   Adverse Side Effects;   AIDS;   HIV Infections
    Interventions:   Genetic: Genetic test for NVP induced rash;   Other: 3TC/D4T/NVP or 3TC/AZT/NVP
    Sponsors:   Mahidol University;   Ramathibodi Hospital;   Department of Medicine,Ramathibodi Hospital;   Chulalongkorn University;   Bamrasnaradura Institute, Ministry of Public Health;   Thammasat University;   Department of Preventive Medicine,Srinakharinwirot University;   Chiang Rai Regional Hospital;   Maharaj Nakornratchasima Hospital;   Department of Internal Medicine,Sawanpracharak Hospital;   Department of Internal Medicine,Burirum Hospital;   Department of Internal Medicine,Nakornping Hospital;   National Institute of Health, Department of Medical Sciences;   Clinical Research Center,Ministry of Public Health;   RIKEN
    Recruiting - verified September 2009
  • Cardiovascular Prevention for Persons With HIV

    Conditions:   HIV Infection;   Cardiovascular Disease Risk
    Interventions:   Drug: Pravastatin;   Drug: Lisinopril
    Sponsors:   Minneapolis Medical Research Foundation;   American Heart Association
    Recruiting - verified October 2009
  • Treatment Failure of Chlamydial Infection in Females in Youth Correctional Facilities

    Condition:   C. Trachomatis
    Interventions:   Drug: Azithromycin;   Drug: Doxycycline
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Not yet recruiting - verified November 2009
  • Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients

    Conditions:   Immune Reconstitution Inflammatory Syndrome;   HIV;   HIV Infections
    Interventions:   Drug: maraviroc;   Drug: Placebo
    Sponsors:   Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran;   University of Witwatersrand, South Africa;   Case Western Reserve University;   Wistar Institute;   University of Pennsylvania
    Not yet recruiting - verified October 2009
  • Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation

    Condition:   Premature Ejaculation
    Interventions:   Drug: Tramadol Hydrochloride;   Drug: Placebo
    Sponsor:   Biovail Laboratories International SRL
    Recruiting - verified October 2009
  • Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels

    Condition:   HIV Infections
    Intervention:   Drug: maraviroc (Selzentry)
    Sponsors:   University of Hawaii;   Pfizer Pharmaceutical
    Not yet recruiting - verified September 2009
  • Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation

    Condition:   Premature Ejaculation
    Intervention:   Drug: Tramadol Hydrochloride & Placebo
    Sponsor:   Biovail Laboratories International SRL
    Recruiting - verified September 2009
  • Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

    Conditions:   Hepatitis C;   HIV Infections
    Interventions:   Drug: telaprevir or matching placebo;   Drug: telaprevir or matching placebo;   Biological: peginterferon alfa-2a;   Drug: ribavirin
    Sponsors:   Vertex Pharmaceuticals Incorporated;   Tibotec Pharmaceutical Limited
    Recruiting - verified November 2009
  • HIV Testing in the Emergency Department at Baystate Medical Center: A Pilot Program

    Condition:   HIV Infections
    Intervention:  
    Sponsors:   Baystate Medical Center;   Massachusetts Department of Health
    Recruiting - verified September 2009
  • A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa

    Condition:   HIV Infections
    Interventions:   Drug: FTC/TDF;   Drug: Placebo
    Sponsor:   International AIDS Vaccine Initiative
    Recruiting - verified November 2009
  • Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers

    Conditions:   HIV-1;   HIV Infections
    Intervention:   Biological: MVA.HIVA
    Sponsors:   Medical Research Council;   European and Developing Countries Clinical Trials Partnership
    Not yet recruiting - verified September 2009
  • The Maraviroc Central Nervous System (CNS) Study

    Condition:   HIV Infections
    Intervention:   Drug: Maraviroc
    Sponsors:   Imperial College London;   Pfizer
    Recruiting - verified September 2009
  • The Raltegravir and Ribavirin Pharmacokinetics (PK) Study

    Condition:   HIV Infections
    Interventions:   Drug: Ribavirin;   Drug: Raltegravir
    Sponsor:   Imperial College London
    Recruiting - verified November 2009
    • Menu
    Find Paid Clinical Trials